Paltiel AD - Search Results

1

Cost-effectiveness of genotype testing for primary resistance in Brazil.

Luz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel AD. Luz PM, et al. Among authors: paltiel ad. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):152-61. doi: 10.1097/QAI.0000000000000426. J Acquir Immune Defic Syndr. 2015. PMID: 25415289 Free PMC article.

2

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.

Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR 3rd, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Goldie SJ, et al. Among authors: paltiel ad. Arch Intern Med. 2002 Apr 22;162(8):921-8. doi: 10.1001/archinte.162.8.921. Arch Intern Med. 2002. PMID: 11966344

3

The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.

Seage GR 3rd, Losina E, Goldie SJ, Paltiel AD, Kimmel AD, Freedberg KA. Seage GR 3rd, et al. Among authors: paltiel ad. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):421-8. doi: 10.1097/00042560-200208010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 12138349

4

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States.

Walensky RP, Paltiel AD, Freedberg KA. Walensky RP, et al. Among authors: paltiel ad. Clin Infect Dis. 2002 Sep 1;35(5):606-10. doi: 10.1086/341903. Epub 2002 Aug 2. Clin Infect Dis. 2002. PMID: 12173137

5

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.

Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Islam R, Freedberg KA. Walensky RP, et al. Among authors: paltiel ad. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):27-37. doi: 10.1097/00126334-200209010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12352147

6

Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.

Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR 3rd, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Yazdanpanah Y, et al. Among authors: paltiel ad. Antivir Ther. 2002 Dec;7(4):257-66. Antivir Ther. 2002. PMID: 12553480

7

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Goldie SJ, et al. Among authors: paltiel ad. Am J Med. 2003 Dec 1;115(8):632-41. doi: 10.1016/j.amjmed.2003.07.007. Am J Med. 2003. PMID: 14656616

8

A therapeutic HIV vaccine: how good is good enough?

Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR 3rd, Smith HE, Zhang H, Freedberg KA. Walensky RP, et al. Among authors: paltiel ad. Vaccine. 2004 Sep 28;22(29-30):4044-53. doi: 10.1016/j.vaccine.2004.03.059. Vaccine. 2004. PMID: 15364455

9

Cost-effectiveness of HIV screening for incarcerated pregnant women.

Resch S, Altice FL, Paltiel AD. Resch S, et al. Among authors: paltiel ad. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):163-73. doi: 10.1097/01.qai.0000146598.40301.e6. J Acquir Immune Defic Syndr. 2005. PMID: 15671801

10

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP. Paltiel AD, et al. N Engl J Med. 2005 Feb 10;352(6):586-95. doi: 10.1056/NEJMsa042088. N Engl J Med. 2005. PMID: 15703423 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page